Gsa Capital Partners LLP Harpoon Therapeutics, Inc. Transaction History

Gsa Capital Partners LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.94 - $2.56 $102,587 - $279,388	109,136 New	109,136 $106,000
Q1 2022 May 11, 2022	SELL	$3.54 - $8.08 $124,841 - $284,949	-35,266 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.69 - $7.83 $59,335 - $81,651	10,428 Added 41.98%	35,266 $266,000
Q3 2021 Nov 12, 2021	BUY	$7.88 - $14.0 $56,570 - $100,506	7,179 Added 40.65%	24,838 $196,000
Q2 2021 Aug 05, 2021	SELL	$13.81 - $23.25 $90,717 - $152,729	-6,569 Reduced 27.11%	17,659 $245,000
Q1 2021 May 10, 2021	SELL	$17.65 - $24.16 $1.05 Million - $1.44 Million	-59,445 Reduced 71.04%	24,228 $507,000
Q4 2020 Feb 03, 2021	BUY	$12.83 - $17.84 $659,846 - $917,511	51,430 Added 159.51%	83,673 $1.39 Million
Q3 2020 Nov 06, 2020	BUY	$11.01 - $18.52 $227,884 - $383,326	20,698 Added 179.28%	32,243 $548,000
Q2 2020 Aug 11, 2020	BUY	$11.11 - $24.72 $128,264 - $285,392	11,545 New	11,545 $192,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.